Cargando…
Correction to: Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546715/ https://www.ncbi.nlm.nih.gov/pubmed/37789369 http://dx.doi.org/10.1186/s40164-023-00447-6 |
| _version_ | 1785114917454479360 |
|---|---|
| author | Hou, Jiangxue Li, Yufu Lin, Quande |
| author_facet | Hou, Jiangxue Li, Yufu Lin, Quande |
| author_sort | Hou, Jiangxue |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10546715 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105467152023-10-04 Correction to: Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting Hou, Jiangxue Li, Yufu Lin, Quande Exp Hematol Oncol Correction BioMed Central 2023-10-03 /pmc/articles/PMC10546715/ /pubmed/37789369 http://dx.doi.org/10.1186/s40164-023-00447-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Hou, Jiangxue Li, Yufu Lin, Quande Correction to: Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting |
| title | Correction to: Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting |
| title_full | Correction to: Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting |
| title_fullStr | Correction to: Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting |
| title_full_unstemmed | Correction to: Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting |
| title_short | Correction to: Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting |
| title_sort | correction to: bispecific antibodies and dual-targeting car-t cells for multiple myeloma: latest updates from the 2023 asco annual meeting |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546715/ https://www.ncbi.nlm.nih.gov/pubmed/37789369 http://dx.doi.org/10.1186/s40164-023-00447-6 |
| work_keys_str_mv | AT houjiangxue correctiontobispecificantibodiesanddualtargetingcartcellsformultiplemyelomalatestupdatesfromthe2023ascoannualmeeting AT liyufu correctiontobispecificantibodiesanddualtargetingcartcellsformultiplemyelomalatestupdatesfromthe2023ascoannualmeeting AT linquande correctiontobispecificantibodiesanddualtargetingcartcellsformultiplemyelomalatestupdatesfromthe2023ascoannualmeeting |